国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2010年
9期
697-699
,共3页
结直肠肿瘤%靶向治疗%遗传异质性
結直腸腫瘤%靶嚮治療%遺傳異質性
결직장종류%파향치료%유전이질성
Colorectal neoplasms%Targeted therapy%Genetic heterogeneity
近年随着肿瘤治疗不断发展,针对基因治疗的药物在肿瘤的降期和局部控制中发挥着重大的作用.结直肠癌内部基因的异质性促进了肿瘤的发生发展,关系着靶向药物选择及疗效,其必然成为肿瘤个体化治疗瓶颈的重要突破点.
近年隨著腫瘤治療不斷髮展,針對基因治療的藥物在腫瘤的降期和跼部控製中髮揮著重大的作用.結直腸癌內部基因的異質性促進瞭腫瘤的髮生髮展,關繫著靶嚮藥物選擇及療效,其必然成為腫瘤箇體化治療瓶頸的重要突破點.
근년수착종류치료불단발전,침대기인치료적약물재종류적강기화국부공제중발휘착중대적작용.결직장암내부기인적이질성촉진료종류적발생발전,관계착파향약물선택급료효,기필연성위종류개체화치료병경적중요돌파점.
Cancer treatment has been continuously improved in recent year. Genetically targeted therapy has played a significant role in tumor reduction and local control. Genetic heterogeneity of colorectal cancer affects not only tumor development and progression, but also the selection and efficiency of targeted drugs, thus may become a breakthrough towards tackling the bottleneck in personalized medicine.